Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...

Union Missionary Baptist Church, in partnership with the Oaklawn Center on Aging, is hosting an opportunity for individuals looking to better manage their diabetes.

Feline diabetes mellitus (DM) is currently understood to have strong similarities to human type 2 diabetes. Veterinarians ...

The cause of death has been confirmed for Michelle Trachtenberg, the 39-year-old actress who was found dead in a New York ...

In diabetes care, AI has propelled the field forward through predictive modeling, decision support, and real-time glycemic ...

Hypoglycemia occurs when levels of blood sugar, or glucose, fall too low; a reading below 70 milligrams per deciliter is an ...

During the time period 2020 to 2023, approximately 1 in 5 youth and 1 in 3 adults with type 1 diabetes and severe obesity ...

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

Combination therapy with GLP-1 RAs and thiazolidinediones is associated with a reduced risk for mortality in patients with T2D, a study finds.

Emerging research has uncovered disturbing links between diabetes during pregnancy and long-term neurodevelopmental outcomes ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...